OatCo

OatCo is a UK-based biotechnology company specializing in the development of high-purity, oat-derived compounds for therapeutic and dermatological applications. The company leverages a proprietary platform to produce avenanthramides, which are natural polyphenols known for their potent anti-inflammatory and anti-itch properties. OatCo's primary focus is on treating inflammatory skin conditions such as atopic dermatitis and psoriasis through topical formulations. By providing a sustainable and scalable source of these bioactive molecules, the company aims to offer safer alternatives to traditional steroid-based treatments. The company is a spin-out from the University of Birmingham and targets both the pharmaceutical and high-end personal care markets.